Evidence map›Paper›PMID 28143602›Full record

ArticleBMC public health2017

Rubella in Sub-Saharan Africa and sensorineural hearing loss: a case control study.

Cristina Caroça, Vera Vicente, Paula Campelo, Maria Chasqueira, Helena Caria, Susana Silva, Paulo Paixão, João Paço

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A Study Prevalence of Congenital Rubella Syndrome Cases Before and After Rubella Vaccination Campaign.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2023
    Article
  5. Cochleovestibular findings linked to COVID-19: A scoping review for clinical care planning in South Africa.The South African journal of communication disorders = Die Suid-Afrikaanse tydskrif vir Kommunikasieafwykings · 2022
    Article
  6. Article
  7. Nanoparticles for the Treatment of Inner Ear Infections.Nanomaterials (Basel, Switzerland) · 2021
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Cristina CaroçaOtolaryngology Department, NOVA Medical School/Faculty of Medical Sciences, Universidade Nova de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056, Lisboa, Portugal. cristinacaroca@netcabo.pt.ORCID 0000-0001-8096-8895
Vera VicenteCEDOC, NOVA Medical School/ Faculty of Medical Sciences, Universidade Nova de Lisboa, Lisboa, Portugal.
Paula CampeloHospital CUF Infante Santo, Avenida Infante Santo, 34, 6°, 1350-079, Lisboa, Portugal.
Maria ChasqueiraCEDOC, NOVA Medical School/ Faculty of Medical Sciences, Universidade Nova de Lisboa, Lisboa, Portugal.
Helena CariaEscola Superior de Tecnologia da Saúde de Lisboa, Avenida D. João II, Lote 4.69.01, 1990-096, Lisboa, Portugal.
Susana SilvaOtolaryngology Department, NOVA Medical School/Faculty of Medical Sciences, Universidade Nova de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056, Lisboa, Portugal.
Paulo PaixãoCEDOC, NOVA Medical School/ Faculty of Medical Sciences, Universidade Nova de Lisboa, Lisboa, Portugal.
João PaçoOtolaryngology Department, NOVA Medical School/Faculty of Medical Sciences, Universidade Nova de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056, Lisboa, Portugal.
Universidade Nova de Lisboa · PTHospital da Luz · PTHospital Universitario Infanta Cristina · ESUniversity of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRubella infection can affect several organs and cause birth defects that are responsible for congenital rubella syndrome (CRS). Congenital hearing loss is the most common symptom of this syndrome, occurring in approximately 60% of CRS cases. Worldwide, over 100 000 babies are born with CRS every year. There is no specific treatment for rubella, but the disease is preventable by vaccination. Since 1969, the rubella vaccine has been implemented in many countries, but in Africa, only a few countries routinely immunize against rubella. The aim of this study was to estimate the rate of infection from the wild-type rubella virus in São Tomé and Príncipe by determining rubella seroprevalence with a DBS method. The goal of this study was to reinforce the need for implementation of the rubella vaccine in this country. As secondary objectives, the validation of a DBS method was first attempted and an association between seroprevalence and hearing loss was assessed.

methodsWe collected samples from individuals observed during humanitarian missions in São Tomé and Príncipe. All individuals underwent an audiometric evaluation, and a drop of blood was collected for the dried blood spot (DBS). We define two groups: the case group (individuals with unilateral or bilateral hearing loss (HL)) and the control group (individuals with two normal ears). Patients were excluded if they suffered from conductive HL, if they showed evidence of possible causes of HL, if they had developmental delay or if they refused to participate in the study.

resultsAmong the 315 subjects, we found 64.1% individuals with IgG for the rubella virus, 32.1% without immunity for the rubella virus and 3.8% who were borderline. In the control group, 62.6% were positive for the rubella IgG, whereas in the case group, 72% were positive. Analyzing both groups, with ages ranging from 2 to 14 years of age and from 15 to 35 years of age, we found a seroprevalence of 50.3% to rubella in the younger group and 82.1% in the older group, with a significant difference between cases and control group noted within the younger patients (p = 0.025).

conclusionsRubella is a disease that can be prevented. Rubella infections are still very common in São Tomé and Príncipe, and women of child-bearing age are still at risk for rubella infection during pregnancy, justifying the urgency of vaccination against rubella. A statistically significant association between the group of children under 14 years of age with HL and immunity for rubella was observed in this country, although this study did not allow us to establish a cause-effect relationship between rubella infection and SNHL.

Indexed as

AdolescentAdultAfrica South of the SaharaCase-Control StudiesChildChild Health ServicesChild, PreschoolFemaleHearing Loss, SensorineuralHumansMaleMedical MissionsRubellaRubella VaccineSeroepidemiologic StudiesVaccinationRubella VaccineCongenital Rubella SyndromeHearing lossRubellaSub-Saharan AfricaWorld Health Organization

Identifiers

PMID28143602
PMCPMC5286841
OpenAlexW2583380641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.